Q32 Bio Operating Income

Q32 Bio (QTTB) currently reports a operating income of $21M as of June 2026. That compares with $-55M in the prior-year period — up 139.2% year over year. Use the charts on this page to explore Q32 Bio's operating income history and peer comparisons.

Q32 Bio's operating income increased from $-55M to $21M — a 139.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Q32 Bio reported $21M in operating income as of June 2026. That compares with $-55M in the prior-year period — up 139.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $21M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Q32 Bio, and consider following QTTB for alerts when major investors trade the stock.

Q32 Bio is classified in the Healthcare sector. On operating income, it currently shows $21M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing QTTB with unrelated industries.